BDBM328434 (S)-tert-butyl (2- (acetamidomethyl)-4-((3- chlorophenyl)sulfonyl)-3,4- dihydro-2H-benzo[b][1,4]oxazin- 6-yl)carbamate::US9663502, 5Q

SMILES CC(=O)NC[C@H]1CN(c2cc(NC(=O)OC(C)(C)C)ccc2O1)S(=O)(=O)c1cccc(Cl)c1

InChI Key InChIKey=VYJFGSLYTROBRQ-KRWDZBQOSA-N

Data  1 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 328434   

TargetNuclear receptor ROR-gamma(Homo sapiens (Human))
Lycera

US Patent
LigandPNGBDBM328434((S)-tert-butyl (2- (acetamidomethyl)-4-((3- chloro...)
Affinity DataIC50:  6.09nMAssay Description:The compounds of the invention inhibit RORgammaT activity. Activation of RORgammaT activity can be measured using, e.g., a biochemical TR-FRET assay....More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent